Daptomycin for Children in Clinical Practice Experience

Authors:
  • SGSilvia Garazzino
    Silvia Garazzino
  • ECElio Castagnola
    Elio Castagnola
  • MGMaria Di Gangi
    Maria Di Gangi
  • RORita Ortolano
    Rita Ortolano
  • AKAndrzej Krzysztofiak
    Andrzej Krzysztofiak
  • ANAgostino Nocerino
    Agostino Nocerino
  • PDPatrizia D’aRgenio
    Patrizia D’aRgenio
  • LGLuisa Galli
    Luisa Galli
  • GLGiuseppe Losurdo
    Giuseppe Losurdo
  • CCCarmelina Calitri
    Carmelina Calitri
  • PTPier-Angelo Tovo
    Pier-Angelo Tovo

Abstract
Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/d, for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.